• -
102 Results
Marijuana medical oil.
Texas Hemp Is Booming: Protect Consumers via Regulation
From 2020 to 2023, sales of hemp-derived cannabinoids increased by 1,283%, reaching a value of $2.78 billion last year. Although the Texas hemp industry is booming, lack of regulation poses risks to public health. A new brief from the Drug Policy Program makes specific recommendations for strengthening and enforcing current laws — ensuring consumer safety while also providing economic benefits for the state.
Drug Policy Program May 31, 2024
Seeds and flower of marijuana with gavel
Baker Briefing: Future of Federal Cannabis Reform
Over half of all Americans live in a state where cannabis is legalized. And yet, the federal government has not reclassified marijuana since 1970. According to the Controlled Substances Act, it is considered a “Schedule 1” substance — the same classification as heroin and crack cocaine with no accepted medical use.
Victoria Jupp, Gary J. Hale, Lisa Pittman February 9, 2024
clean energy
Federal Energy Legislation and the Infrastructure Achilles’ Heel: The Energy Market Impacts of the IIJA, CHIPS Act, and IRA
The U.S. has taken major legislative steps through the Infrastructure Investment and Jobs Act, CHIPS Act and Inflation Reduction Act to advance clean energy technologies and bolster national energy security. But for these measures to bear full fruit, policymakers will need to address critical infrastructure barriers, writes the Center for Energy Studies' Kenneth B. Medlock III.
Kenneth B. Medlock III August 7, 2023